PositoAI
a positivity index
Home Explore Actions Flows Indices News Watchlist Compare PosiDemy Screeners Insights
PosiFunda · Fundamentals

Care Twentyone Corporation

PosiFunda Ratios Only on PositoAI

PositoAI's own ratios from Care Twentyone Corporation's yearly results (2022–2025), compared with Healthcare companies in Japan. Tap ? on any ratio for what it means.

What stands out

  • Cash Cushion Ratio: Debt, after subtracting cash, is 2.6 times its market value (net debt). Lower than 97% of Healthcare companies in Japan.

Where ¥100 of sales goes

¥98Operating costs¥1.0Interest¥0.8Net profit¥0.5Paid as dividends

Latest year (Oct 2025). Taxes and other income are not shown, so the parts need not add up to 100.

Cash quality

Profit Cash Ratio

—

Loss-making or profit too small

Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.

Self-Funding Ratio

1.6×

Over the last 3 years its own operating cash covered its investment spending (capex) 1.6 times.

Higher than 54% of Healthcare companies in Japan.

Cash Locked Ratio

¥5

For every ¥100 of sales, ¥5 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against ¥5 tied up three years earlier.

Less money tied up than 70% of Healthcare companies in Japan.

Growth quality

Steadiness Ratio

3/3 · 2/3

Sales grew in 3 of the last 3 years; profit grew in 2 of 3.

Steadier than 71% of Healthcare companies in Japan.

Growth Efficiency Ratio

−¥3

Sales grew 25% in 3 years, but profit fell: ¥3 less profit per ¥100 of extra sales.

Lower than 76% of Healthcare companies in Japan.

Asset Productivity Ratio

+25% / -15%

In 3 years sales changed by +25% while total assets changed by -15%. Sales grew faster than assets.

Balance-sheet strength

Debt Due Cover Ratio

0.5×

Debt due within a year is covered 0.5 times by its yearly operating cash.

Lower than 57% of Healthcare companies in Japan.

Cash Cushion Ratio

2.6× debt

Debt, after subtracting cash, is 2.6 times its market value (net debt).

Lower than 97% of Healthcare companies in Japan.

Tangible Assets Ratio

98%

Of every ¥100 the company owns, ¥98 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.

More tangible than 64% of Healthcare companies in Japan.

Tangible Net Worth Ratio

89%

Of every ¥100 of net worth, ¥89 is tangible; the rest is goodwill and other intangibles, often from buying other companies.

Less tangible than 59% of Healthcare companies in Japan.

Shareholders

Shareholder Slice Ratio

0%

Share count was unchanged over the last 3 years. Dividends paid equalled 103% of profit over the same period.

Standard fundamentals

P/E, P/B, ROE, debt, growth and more (14)

Care Twentyone Corporation owes ¥0.85 for every ¥1 it owns. Net profit rose 38% in the year to Oct 2025, and shrank 15% a year on average over 3 years.

Compared with Healthcare companies in Japan · latest annual results Oct 2025.

P/E ratio

18.4

Investors pay ¥18.4 for every ¥1 of Care Twentyone Corporation's yearly profit, higher than 63% of Healthcare companies in Japan.

P/B ratio

1.14

The share price is 1.14 times Care Twentyone Corporation's book value per share, lower than 68% of Healthcare companies in Japan.

Market cap

¥5.3 B

The total market value of all of Care Twentyone Corporation's shares at today's price (share price × number of shares), smaller than 79% of Healthcare companies in Japan. PosiCap size class: Micro Cap.

Net worth (book value)

¥4.7 B

What Care Twentyone Corporation would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (31 Jul 2026).

Book value per share

¥343.87

Net worth divided by the number of shares. The share price of ¥392.00 is 1.1 times this, which is the P/B above.

Return on equity (ROE)

7.2%

Care Twentyone Corporation earned 7.2% on its shareholders' money over the last year, higher than 50% of Healthcare companies in Japan.

Owes vs Owns

0.85×

Care Twentyone Corporation owes ¥0.85 for every ¥1 it owns (high), higher than 95% of Healthcare companies in Japan.

Dividend yield

4.07%

Care Twentyone Corporation pays 4.07% of its share price as dividends a year, higher than 86% of dividend-paying Healthcare companies in Japan.

Revenue growth

+6%

Revenue rose 6% in the year to Oct 2025, and grew 8% a year on average over 3 years.

Profit growth

+38%

Net profit rose 38% in the year to Oct 2025, and shrank 15% a year on average over 3 years.

Profit margin

0.8%

Care Twentyone Corporation keeps ¥1 of every ¥100 of revenue as net profit.

Cash quality

5.7×

Cash from Care Twentyone Corporation's business was 5.7× its reported profit in the year to Oct 2025 — its profit turned into cash.

Interest cover

1.6×

Care Twentyone Corporation's operating profit covered its interest costs 1.6 times in the year to Oct 2025.

Cash vs debt

Net debt

Care Twentyone Corporation had ¥14.4 B more debt than cash (net debt) at Oct 2025.

Questions

What is Care Twentyone Corporation's P/E ratio?

Investors pay ¥18.4 for every ¥1 of Care Twentyone Corporation's yearly profit, higher than 63% of Healthcare companies in Japan.

How is P/B calculated on PositoAI?

P/B is market cap divided by net worth from the latest balance sheet. For Care Twentyone Corporation: ¥5.3 B ÷ ¥4.7 B (31 Jul 2026) = 1.1.

What is Care Twentyone Corporation's return on equity?

Care Twentyone Corporation earned 7.2% on its shareholders' money over the last year, higher than 50% of Healthcare companies in Japan.

How much does Care Twentyone Corporation owe compared with what it owns?

Care Twentyone Corporation owes ¥0.85 for every ¥1 it owns (high), higher than 95% of Healthcare companies in Japan.

Does Care Twentyone Corporation pay a dividend?

Yes. Care Twentyone Corporation pays 4.07% of its share price as dividends a year, higher than 86% of dividend-paying Healthcare companies in Japan.

Is Care Twentyone Corporation's revenue growing?

Revenue rose 6% in the year to Oct 2025, and grew 8% a year on average over 3 years.

Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.